 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1ha6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Nmr solution structure of murine ccl20/mip-3a chemokine
|
|
Structure:
|
 |
Macrophage inflammatory protein 3 alpha. Chain: a. Synonym: mip-3-alpha, cc chemokine larc
|
|
Source:
|
 |
Synthetic: yes. Mus musculus. Mouse. Organism_taxid: 10090. Tissue: muscle. Cellular_location: secreted
|
|
NMR struc:
|
 |
20 models
|
 |
|
Authors:
|
 |
J.M.Perez-Canadillas,A.Zaballos,J.Gutierrez,R.Varona, F.Roncal,J.P.Albar,G.Marquez,M.Bruix
|
Key ref:
|
 |
J.M.Pérez-Cañadillas
et al.
(2001).
NMR solution structure of murine CCL20/MIP-3alpha, a chemokine that specifically chemoattracts immature dendritic cells and lymphocytes through its highly specific interaction with the beta-chemokine receptor CCR6.
J Biol Chem,
276,
28372-28379.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
28-Mar-01
|
Release date:
|
22-Aug-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
O89093
(CCL20_MOUSE) -
C-C motif chemokine 20
|
|
|
|
Seq: Struc:
|
 |
 |
 |
97 a.a.
70 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
immune response
|
3 terms
|
 |
|
Biochemical function
|
protein binding
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
276:28372-28379
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
NMR solution structure of murine CCL20/MIP-3alpha, a chemokine that specifically chemoattracts immature dendritic cells and lymphocytes through its highly specific interaction with the beta-chemokine receptor CCR6.
|
|
J.M.Pérez-Cañadillas,
A.Zaballos,
J.Gutiérrez,
R.Varona,
F.Roncal,
J.P.Albar,
G.Márquez,
M.Bruix.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
CCL20/MIP-3alpha is a beta-chemokine expressed in the thymus, skin, and
intestinal epithelial cells that exclusively binds and activates the CCR6
receptor in both mice and humans. The strict receptor binding specificity of
CCL20 is exceptional; other chemokines and their receptors bind promiscuously
with multiple partners. Toward determining the structural basis for the
selective receptor specificity of CCL20, we have determined its
three-dimensional structure by 1H NMR spectroscopy. CCL20 exhibits the same
monomeric structure previously described for other chemokines: a three-stranded
beta-sheet and an overlying alpha-helix. The CCL20 receptor selectivity could
arise from the rigid conformation of the N-terminal DCCL motif as well as the
groove between the N-loop and the beta2-beta3 hairpin, which is significantly
narrower in CCL20 than in other chemokines. Similar structural features are seen
in human beta-defensin 2, a small nonchemokine polypeptide reported to
selectively bind and activate CCR6, which stresses their importance for the
specific binding of both CCL20 and beta-defensin 2 to CCR6. CCL20's structure
will be useful to design tools aimed to modulate its important biological
functions.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Stereoscopic views of the CCL20 solution
structure. Superposition of the 20 structures with the N
terminus on the right and the C terminus on the left side and
-helix face
(top) and N-loop face (middle). Bottom, ribbon representation of
the lowest energy CCL20 structure in the N-loop face orientation.
|
 |
Figure 6.
Fig. 6. Ribbon representation of the chemokine CCL20
(left) and the -defensin
BD2 (37) (right). -Sheets are
represented by arrows; arginine and lysine residues are shown in
blue; Asp5 in CCL20 and Asp4 in BD2 are depicted in red; and
Leu8 in CCL20 and Leu9 in BD2 are shown in green.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2001,
276,
28372-28379)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
I.Comerford,
M.Bunting,
K.Fenix,
S.Haylock-Jacobs,
W.Litchfield,
Y.Harata-Lee,
M.Turvey,
J.Brazzatti,
C.Gregor,
P.Nguyen,
E.Kara,
and
S.R.McColl
(2010).
An immune paradox: How can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: A chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
|
| |
Bioessays, 32,
1067-1076.
|
 |
|
|
|
|
 |
S.N.Haddad,
and
C.R.Wira
(2010).
Keratinocyte Growth Factor Stimulates Macrophage Inflammatory Protein 3α and Keratinocyte-derived Chemokine Secretion by Mouse Uterine Epithelial Cells.
|
| |
Am J Reprod Immunol, 64,
197-211.
|
 |
|
|
|
|
 |
Y.Shintani,
Y.Terao,
and
H.Ohta
(2010).
Molecular mechanisms underlying hypothermia-induced neuroprotection.
|
| |
Stroke Res Treat, 2011,
809874.
|
 |
|
|
|
|
 |
D.I.Chan,
H.N.Hunter,
B.F.Tack,
and
H.J.Vogel
(2008).
Human macrophage inflammatory protein 3alpha: protein and peptide nuclear magnetic resonance solution structures, dimerization, dynamics, and anti-infective properties.
|
| |
Antimicrob Agents Chemother, 52,
883-894.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.O.Ochiel,
J.V.Fahey,
M.Ghosh,
S.N.Haddad,
and
C.R.Wira
(2008).
Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens.
|
| |
Curr Womens Health Rev, 4,
102-117.
|
 |
|
|
|
|
 |
A.P.Phadke,
G.Akangire,
S.J.Park,
S.A.Lira,
and
B.Mehrad
(2007).
The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis.
|
| |
Am J Respir Crit Care Med, 175,
1165-1172.
|
 |
|
|
|
|
 |
B.Begue,
C.Dumant,
J.C.Bambou,
J.F.Beaulieu,
M.Chamaillard,
J.P.Hugot,
O.Goulet,
J.Schmitz,
D.J.Philpott,
N.Cerf-Bensussan,
and
F.M.Ruemmele
(2006).
Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
|
| |
J Cell Physiol, 209,
241-252.
|
 |
|
|
|
|
 |
E.Klüver,
K.Adermann,
and
A.Schulz
(2006).
Synthesis and structure-activity relationship of beta-defensins, multi-functional peptides of the immune system.
|
| |
J Pept Sci, 12,
243-257.
|
 |
|
|
|
|
 |
G.Soboll,
M.A.Crane-Godreau,
M.A.Lyimo,
and
C.R.Wira
(2006).
Effect of oestradiol on PAMP-mediated CCL20/MIP-3 alpha production by mouse uterine epithelial cells in culture.
|
| |
Immunology, 118,
185-194.
|
 |
|
|
|
|
 |
X.Lu,
Z.Kurago,
and
K.A.Brogden
(2006).
Effects of polymicrobial communities on host immunity and response.
|
| |
FEMS Microbiol Lett, 265,
141-150.
|
 |
|
|
|
|
 |
Z.A.Malik,
and
B.F.Tack
(2006).
Structure of human MIP-3alpha chemokine.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 62,
631-634.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Yang,
A.Biragyn,
D.M.Hoover,
J.Lubkowski,
and
J.J.Oppenheim
(2004).
Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense.
|
| |
Annu Rev Immunol, 22,
181-215.
|
 |
|
|
|
|
 |
L.S.Ai,
S.F.Lee,
S.S.Chen,
and
F.Liao
(2004).
Molecular characterization of CCR6: involvement of multiple domains in ligand binding and receptor signaling.
|
| |
J Biomed Sci, 11,
818-828.
|
 |
|
|
|
|
 |
N.Antcheva,
M.Boniotto,
I.Zelezetsky,
S.Pacor,
M.V.Verga Falzacappa,
S.Crovella,
and
A.Tossi
(2004).
Effects of positively selected sequence variations in human and Macaca fascicularis beta-defensins 2 on antimicrobial activity.
|
| |
Antimicrob Agents Chemother, 48,
685-688.
|
 |
|
|
|
|
 |
A.I.Yudin,
T.L.Tollner,
M.W.Li,
C.A.Treece,
J.W.Overstreet,
and
G.N.Cherr
(2003).
ESP13.2, a member of the beta-defensin family, is a macaque sperm surface-coating protein involved in the capacitation process.
|
| |
Biol Reprod, 69,
1118-1128.
|
 |
|
|
|
|
 |
E.Schutyser,
S.Struyf,
and
J.Van Damme
(2003).
The CC chemokine CCL20 and its receptor CCR6.
|
| |
Cytokine Growth Factor Rev, 14,
409-426.
|
 |
|
|
|
|
 |
T.Oono,
W.K.Huh,
Y.Shirafuji,
H.Akiyama,
and
K.Iwatsuki
(2003).
Localization of human beta-defensin-2 and human neutrophil peptides in superficial folliculitis.
|
| |
Br J Dermatol, 148,
188-191.
|
 |
|
|
|
|
 |
B.C.Schutte,
J.P.Mitros,
J.A.Bartlett,
J.D.Walters,
H.P.Jia,
M.J.Welsh,
T.L.Casavant,
and
P.B.McCray
(2002).
Discovery of five conserved beta -defensin gene clusters using a computational search strategy.
|
| |
Proc Natl Acad Sci U S A, 99,
2129-2133.
|
 |
|
|
|
|
 |
D.Yang,
A.Biragyn,
L.W.Kwak,
and
J.J.Oppenheim
(2002).
Mammalian defensins in immunity: more than just microbicidal.
|
| |
Trends Immunol, 23,
291-296.
|
 |
|
|
|
|
 |
H.J.Vogel,
D.J.Schibli,
W.Jing,
E.M.Lohmeier-Vogel,
R.F.Epand,
and
R.M.Epand
(2002).
Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides.
|
| |
Biochem Cell Biol, 80,
49-63.
|
 |
|
|
|
|
 |
M.Dürr,
and
A.Peschel
(2002).
Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense.
|
| |
Infect Immun, 70,
6515-6517.
|
 |
|
|
|
|
 |
R.I.Lehrer,
and
T.Ganz
(2002).
Defensins of vertebrate animals.
|
| |
Curr Opin Immunol, 14,
96.
|
 |
|
|
|
|
 |
T.Ganz
(2002).
Immunology. Versatile defensins.
|
| |
Science, 298,
977-979.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|